Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-06-27T18:27:36.805Z Has data issue: false hasContentIssue false

Case 86 - Langerhans cell histiocytosis: MRI/PET for diagnosis and treatment monitoring

from Section 9 - Musculoskeletal imaging

Published online by Cambridge University Press:  05 June 2014

Wolfgang P. Fendler
Affiliation:
University Hospital of the Ludwig–Maximilians–Universität
Eva Coppenrath
Affiliation:
Technische Universität München,
Klemens Scheidhauer
Affiliation:
Technische Universität München
Thomas Pfluger
Affiliation:
Technische Universität München
Heike E. Daldrup-Link
Affiliation:
Lucile Packard Children's Hospital, Stanford University
Beverley Newman
Affiliation:
Lucile Packard Children's Hospital, Stanford University
Get access

Summary

Imaging description

A 12-year-old boy presented with chronic pain of the right knee. The pain became gradually worse over a three-month period and increased with pressure and after long walks. There was no history of trauma. On physical examination, no swelling or redness of the right knee was noted. Mild external rotation of the right hip as well as limited active and passive internal rotation was seen on examination.

An X-ray of the right knee was unremarkable. An X-ray of the right hip showed a focal, well-defined, round osteolytic lesion with a diameter of approximately 1 cm in the inferior acetabulum (Fig. 86.1). An MRI and 18F-FDG PET were performed for further evaluation. T2 STIR images demonstrated a more extensive hyperintense lesion in the right ischium and an additional hyperintense lesion in the right femur (Fig. 86.2). These lesions showed enhancement on contrast-enhanced T1-weighted MR scans (not shown) and increased metabolic activity on 18F-FDG PET (Fig. 86.2). The diagnosis of Langerhans cell histiocytosis (LCH) was established by CT-guided biopsy and histopathology. Chemotherapy according to the LCH-III protocol was initiated and well tolerated by the patient. Follow-up simultaneous 18F-FDG PET/MR scans performed after treatment showed complete remission of both lesions. However, a new T2-hyperintense lesion was noted in the right ilium, which demonstrated normal 18F-FDG uptake (Fig. 86.3). It was assumed that this lesion had occurred after the initial 18F-FDG PET/MR scans and had been successfully treated as well. Thus, a conservative strategy without further systemic chemotherapy was chosen and a follow-up MRI after six months confirmed reduced lesion size.

Type
Chapter
Information
Pearls and Pitfalls in Pediatric Imaging
Variants and Other Difficult Diagnoses
, pp. 350 - 353
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abla, O, Egeler, RM, Weitzman, S. Langerhans cell histiocytosis: current concepts and treatments. Cancer Treat Rev 2010;36(4):354–9.CrossRefGoogle ScholarPubMed
Broadbent, V, Gadner, H. Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:327–38.CrossRefGoogle ScholarPubMed
Carstensen, H, Ornvold, K. [Langerhans-cell histiocytosis (histiocytosis X) in children]. Ugeskr Laeger 1993;155(23):1779–83.Google Scholar
Carstensen, H, Ornvold, K. The epidemiology of Langerhans cell histiocytosis in children in Denmark. Med Pediatr Oncol 1993;21:387–8.Google Scholar
Gadner, H, Grois, N, Arico, M, et al. A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis. J Pediatr 2001;138(5):728–34.CrossRefGoogle ScholarPubMed
Howarth, DM, Gilchrist, GS, Mullan, BP, et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999;85:2278–90.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Kaste, SC, Rodriguez-Galindo, C, McCarville, ME, et al. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007;37(7):615–22.CrossRefGoogle ScholarPubMed
Minkov, M, Grois, N, Heitger, A, et al. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 2002;39(6):581–5.CrossRefGoogle Scholar
Phillips, M, Allen, C, Gerson, P, et al. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009;52(1):97–101.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×